Michael James Elliott - Net Worth and Insider Trading

Michael James Elliott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael James Elliott owns 2 companies in total, including Immunovant Inc (IMVTU) , and Immunovant Inc (IMVT) .

Click here to see the complete history of Michael James Elliott’s form 4 insider trades.

Insider Ownership Summary of Michael James Elliott

Ticker Comapny Transaction Date Type of Owner
IMVTU Immunovant Inc 2020-09-04 Chief Scientific Officer
IMVT Immunovant Inc 2020-08-24 Chief Scientific Officer

Michael James Elliott Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael James Elliott Ownership Network

Ownership Network List of Michael James Elliott

No Data

Ownership Network Relation of Michael James Elliott


Michael James Elliott Owned Company Details

What does Immunovant Inc do?

Who are the key executives at Immunovant Inc?

Michael James Elliott is the Chief Scientific Officer of Immunovant Inc. Other key executives at Immunovant Inc include 10 percent owner Roivant Sciences Ltd. , Chief Dev. & Tech. Officer Julia G. Butchko , and director & Chief Executive Officer Peter Salzmann .

Immunovant Inc (IMVTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunovant Inc Insider Transactions

No Available Data

Michael James Elliott Mailing Address

Above is the net worth, insider trading, and ownership report for Michael James Elliott. You might contact Michael James Elliott via mailing address: 320 West 37th Street, New York Ny 10018.

Discussions on Michael James Elliott

No discussions yet.